Lori M. Waldron

Lori M. Waldron is Chair of the Life Sciences Practice Group at Sills Cummis & Gross. She is a trusted transactional advisor to emerging growth, middle market and established public and private companies across the life sciences ecosystem. Her practice is concentrated on biotechnology, pharmaceutical, specialty pharma, medical device, diagnostics and healthcare-adjacent companies, as well as the investors, founders and strategic partners that support them.

Lori Waldron is known for guiding life sciences companies through transformative transactions and complex strategic growth initiatives. Her practice includes sophisticated mergers and acquisitions, licensing and sublicensing transactions, joint ventures, divestitures and other strategic combinations involving proprietary technologies, therapeutic platforms, intellectual property portfolios and FDA-regulated products and services. She counsels clients on R&D, supply and commercialization arrangements and other critical operational and transactional matters unique to regulated life sciences businesses.

View Lori Waldron’s full attorney profile: www.sillscummis.com/professionals/lori-waldron/

Villanova University School of Law

J.D., cum laude, Order of the Coif

Villanova University

M.B.A., B.S.